Gray matter blood‐brain barrier water exchange dynamics are reduced in progressive multiple sclerosis
Source : https://onlinelibrary.wiley.com/doi/10.1111/jon.12912?af=R
Experimental Laboratory Research Ian J Tagge , Valerie C Anderson , Charles S Springer Jr. , Manoj K Sammi , Dennis M Bourdette , Rebecca I Spain , William D...
Targeting Nuclear Factor-Kappa B Signaling Pathway by Curcumin: Implications for the Treatment of Multiple Sclerosis
Source : https://link.springer.com/chapter/10.1007/978-3-030-56153-6_3
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1291) Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system, which involves an...
In vivo evidence of differential frontal cortex metabolic abnormalities in progressive and relapsing-remitting multiple sclerosis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34318959/
doi: 10.1002/nbm.4590. Online ahead of print. 1 Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut. 2 Department of Biomedical Engineering, Columbia University School of...
Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology | TCRM
Multiple Sclerosis (MS) is a chronic autoimmune and neurodegenerative disease of the central nervous system (CNS) that typically affects young adults, with an onset between 20 and 40 years of...
Longitudinal change in TSPO PET imaging in progressive multiple sclerosis
Source : https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.51431
The objective of this pilot study was to assess a 2-year change in innate immune burden in 15 progressive multiple sclerosis (MS) patients using PK11195-PET. Sixteen age-matched healthy controls (HC)...